ADVERTISEMENT

Select Columnist:
Nagahiro Saijo, MD, PhD

Nagahiro Saijo, MD, PhD

Nagahiro Saijo, MD, PhD
Professor, Medical Oncology Division
Kinki University School of Medicine
Osaka, Japan

Dr. Saijo is a member of The ASCO Post's International Editorial Advisory Board.

Latest Articles

  • Multinational Trials Reveal Striking Regional Differences - Tuesday, August 09, 2011

Read Bio

Read Bio

  • Breast cancer (152)
  • Direct from ASCO (55)
  • Lung cancer (67)
  • Lymphoma (49)
  • Prostate cancer (44)
  • Leukemia (30)
  • Other (31)
  • Colorectal cancer (23)
  • Gastrointestinal cancer (27)
  • Appointments (18)
  • Melanoma (20)
  • Multiple myeloma (18)
  • Perspective (19)
  • Genitourinary cancer (25)
  • Colon cancer (14)
  • more...

ADVERTISEMENT

ADVERTISEMENT



#FDA’s $6.4 Billion Plan For Quick Reviews Moves To Senate (via Bloomberg) http://t.co/NGMtNfBk
about 13 hours ago via web

#LungCancer CT Scans: Just for Older Heavy #Smokers (via AP) http://t.co/7j0lqhGm
about 15 hours ago via web

#Immunotherapy Clinical Trials Show Benefits for Patients with Advanced #Cancer http://t.co/jma6OOYG
about 15 hours ago via web

Dr. James A. Stewart on Maintenance of Certification in Medical #Oncology http://t.co/6xcTrMqj
about 15 hours ago via web

.@SalpyTalatinian Thanks for the retweet!
about 3 days ago via web

© 2012 HSP News Service, L.L.C.
Advertising  |  Disclosures  |  Contact TAP  |  Privacy Policy  |  Disclaimer